ARQL Insider Trading Activity and SEC Form 4 Filings
ARQL insider trading summary
No open-market insider purchases or sales of Arqule Inc (ARQL) have been reported on SEC Form 4 in the past 12 months.
Latest ARQL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 27, 2019 | Ran Nussbaum | Director | Buy | $360K (36,923 @ $9.75) |
| Jun 27, 2019 | Ran Nussbaum | Director | Buy | $704K (72,205 @ $9.75) |
| Jun 27, 2019 | Ran Nussbaum | Director | Buy | $1.3M (133,548 @ $9.75) |
| Jun 27, 2019 | Ran Nussbaum | Director | Buy | $634K (65,016 @ $9.75) |
| Jul 13, 2018 | Ran Nussbaum | Director | Buy | $240K (43,657 @ $5.50) |
| Jul 13, 2018 | Ran Nussbaum | Director | Buy | $267K (48,485 @ $5.50) |
| Jul 13, 2018 | Ran Nussbaum | Director | Buy | $493K (89,676 @ $5.50) |
| May 30, 2018 | BVF Partners OS Ltd. | Insider | Sell | $2.7M (547,860 @ $5.00) |
| May 30, 2018 | Bvf Partners L P/Il | 10% Owner | Sell | $2.7M (547,860 @ $5.00) |
| May 30, 2018 | Biotechnology Value Fund L P | Insider | Sell | $2.7M (547,860 @ $5.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.